Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Belgium Health Review.
Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases
GlobeNewswire, Inc.
·
March 24, 2025
Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases Proceeds from the financing will advance Augustine’s lead...
Healthcare Adhesive Tapes Market Estimation Worth USD 15.43 Billion By 2030 –Exactitude Consultancy
EIN Presswire
·
January 29, 2025
Global Healthcare Adhesive Tapes Market Include - Medtronic PLC, 3M Company, Avery Dennison Corporation, Medline Industries CALIFORNIA, CA, UNITED STATES, January 29, 2025 /EINPresswire.com/ -- A newly released report on the Healthcare Adhesive...
ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast
GlobeNewswire, Inc.
·
March 19, 2025
EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people...
Press release: Sequana Medical Obtains Convertible Financing of EUR 4.0 Million from Major Shareholders and Committed Share Subscription Facility of up to EUR 60 Million from GEM
GlobeNewswire, Inc.
·
March 18, 2025
Sequana Medical Obtains Convertible Financing of EUR 4.0 Million from Major Shareholders and Committed Share Subscription Facility of up to EUR 60 Million from GEM Continued support from major shareholders – new EUR 4.0 million convertible loan...
Smart Infusion Pumps Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
EIN Presswire
·
July 3, 2025
The Business Research Company’s Smart Infusion Pumps Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, July 3, 2025 /EINPresswire.com/ -- Is The Smart Infusion Pumps Market Poised For...
AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound
GlobeNewswire, Inc.
·
June 30, 2025
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85th Annual Meeting this week in Chicago for its novel...
Gifftid debuts its AI driven healthcare impact entrepreneurship for clinical research in South Africa
EIN Presswire
·
November 12, 2024
Gifftid Launches Healthcare Impact Builder, Transforming Clinical Research in South Africa through Impact Entrepreneurship LONDON, BELGIUM, November 12, 2024 /EINPresswire.com/ -- Gifftid Ltd proudly announces the launch of its Healthcare Impact...
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
GlobeNewswire, Inc.
·
March 10, 2025
WEST LAFAYETTE, Ind., March 10, 2025 (GLOBE NEWSWIRE) -- Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety...
$6.7 Billion Laboratory Consumables Market by 2034: Growth in Germany, Belgium, and Netherlands Fueled by Increasing R&D Investments – Analysis by TMR
GlobeNewswire, Inc.
·
March 11, 2025
Wilmington, Delaware, Transparency Market Research Inc. –, March 11, 2025 (GLOBE NEWSWIRE) -- The laboratory consumables market in Germany, Belgium, and the Netherlands is witnessing significant growth, fueled by rising R&D investments,...
Medical Elastomer Market worth $14.27 billion by 2029, at a CAGR of 8.3 % says MarketsandMarkets™
GlobeNewswire, Inc.
·
January 13, 2025
Delray Beach, FL, Jan. 12, 2025 (GLOBE NEWSWIRE) -- The Global Medical Elastomer Market size is expected to reach USD 14.27 billion by 2029 from USD 9.57 billion in 2024, at a CAGR of 8.3% from 2024 to 2029, as per the recent study by...
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event
GlobeNewswire, Inc.
·
March 5, 2025
Event to include updates on ongoing evorpacept clinical development program and introduction of clinical trials in breast and colorectal cancers Advancing novel EGFR-targeted antibody-drug conjugate (ADC) candidate, ALX2004, into clinical-stage...
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
GlobeNewswire, Inc.
·
March 3, 2025
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – March 3, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that...
Leading Factor Driving The Market In 2025: Impact Of Growing Healthcare Infrastructure Demand On The Bimzelx Dosage
EIN Presswire
·
March 4, 2025
The Business Research Company's Bimzelx Dosage Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 4, 2025 /EINPresswire.com/ -- What Are the Projections for the Bimzelx...
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
GlobeNewswire, Inc.
·
February 25, 2025
MELBOURNE, Australia and INDIANAPOLIS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) announces that the Biogenix Molecular Research Center in Miami, FL, is recruiting and dosing...
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
GlobeNewswire, Inc.
·
February 27, 2025
An independent Data Safety Monitoring Board (DSMB) for the Phase 3 DRAGON trial recommends trial continuation without any modifications, maintaining the sample size at 104 subjects following a planned interim efficacy analysis; trial completion...
SYNERGIA MEDICAL ANNOUNCES STRONG RESULTS FOR NAO.VNS™ FIRST-IN-HUMAN STUDY
GlobeNewswire, Inc.
·
February 24, 2025
Primary safety endpoint met - No serious adverse events reported over 3-months Robust device performance - No device failure reported over 3-months Synergia Medical announces that its NAO.VNS™ device, successfully implanted in five patients at UZ...
Human Nutrition Market Size to Reach $75 billion by 2034 Growing at 5.3% CAGR Exactitude Consultancy
EIN Presswire
·
February 25, 2025
Global Human Nutrition Market Include– Nestlé S.A., PepsiCo, Inc., The Kraft Heinz Company, Danone S.A CALIFORNIA, CA, UNITED STATES, February 25, 2025 /EINPresswire.com/ -- The report has offered an all-inclusive analysis of the global Human...
Arch Biopartners Announces Health Canada No Objection Letter (NOL) Granted for Investigator-Led Phase II PONTiAK Trial Using Cilastatin to Target Drug-Toxin-Related Acute Kidney Injury (AKI)
GlobeNewswire, Inc.
·
February 18, 2025
TORONTO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the clinical team leading the upcoming investigator-led trial, titled “Prevention Of NephroToxin...
Gilde Healthcare announces successful sale of health-IT software company Performation to Enovation, part of Legrand
GlobeNewswire, Inc.
·
February 13, 2025
Gilde Healthcare announces successful sale of health-IT software company Performation to Enovation, part of Legrand Exit confirms Gilde's investment strategy of building market-leading healthcare companies that deliver better care at lower cost...
Augustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic
GlobeNewswire, Inc.
·
February 13, 2025
Augustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD, current Executive Chairman, appointed as CEO Best-in-class highly selective HDAC6 inhibitor...